Endoplasmic Reticulum Homeostasis Regulates TLR4 Expression and Signaling in Mast Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Oct 2022
Historique:
received: 24 08 2022
revised: 08 09 2022
accepted: 13 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

The endoplasmic reticulum (ER) is a dynamic organelle that responds to demand in secretory proteins by undergoing expansion. The mechanisms that control the homeostasis of ER size and function involve the activation of the unfolded protein response (UPR). The UPR plays a role in various effector functions of immune cells. Mast cells (MCs) are highly granular tissue-resident cells and key drivers of allergic inflammation. Their diverse secretory functions in response to activation through the high-affinity receptor for IgE (FcεRI) suggest a role for the UPR in their function. Using human cord blood-derived MCs, we found that FcεRI triggering elevated the expression level and induced activation of the UPR transducers IRE1α and PERK, accompanied by expansion of the ER. In mouse bone marrow-derived MCs and peritoneal MCs, the ER underwent a more moderate expansion, and the UPR was not induced following MC activation. The deletion of IRE1α in mouse MCs did not affect proliferation, survival, degranulation, or cytokine stimulation following FcεRI triggering, but it did diminish the surface expression of TLR4 and the consequent response to LPS. A similar phenotype was observed in human MCs using an IRE1α inhibitor. Our data indicate that the ER of MCs, primarily of humans, undergoes a rapid remodeling in response to activation that promotes responses to TLR4. We suggest that IRE1α inhibition can be a strategy for inhibiting the hyperactivation of MCs by LPS over the course of allergic responses.

Identifiants

pubmed: 36233127
pii: ijms231911826
doi: 10.3390/ijms231911826
pmc: PMC9569687
pii:
doi:

Substances chimiques

Cytokines 0
Lipopolysaccharides 0
Receptors, IgE 0
TLR4 protein, human 0
Tlr4 protein, mouse 0
Toll-Like Receptor 4 0
Immunoglobulin E 37341-29-0
ERN1 protein, human EC 2.7.11.1
Protein Serine-Threonine Kinases EC 2.7.11.1
Endoribonucleases EC 3.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Israel Science Foundation
ID : 254/20
Organisme : German Israeli Foundation
ID : I-1471-414.13/2018

Références

EMBO J. 2020 Sep 1;39(17):e105696
pubmed: 32716134
J Allergy Clin Immunol. 2011 May;127(5):1267-76.e6
pubmed: 21333342
Front Immunol. 2021 Feb 19;12:604974
pubmed: 33679742
Nat Immunol. 2015 Aug;16(8):829-37
pubmed: 26147683
Int J Mol Sci. 2019 Mar 20;20(6):
pubmed: 30897694
J Immunol. 2008 Oct 15;181(8):5433-41
pubmed: 18832700
Front Immunol. 2021 Jun 17;12:664668
pubmed: 34220812
Neurochem Res. 2022 Jun;47(6):1598-1609
pubmed: 35171433
J Cell Biol. 2009 Aug 10;186(3):323-31
pubmed: 19651891
Nat Cell Biol. 2001 Oct;3(10):891-6
pubmed: 11584270
EMBO J. 2006 Feb 22;25(4):683-92
pubmed: 16467847
Lipids Health Dis. 2015 Jul 16;14:73
pubmed: 26174230
Blood. 2006 Jan 15;107(2):610-8
pubmed: 16174756
Adv Immunol. 2015;125:41-85
pubmed: 25591464
Cell Mol Life Sci. 2016 Mar;73(6):1265-85
pubmed: 26407610
J Autoimmun. 2014 May;50:59-66
pubmed: 24387801
Cell Death Differ. 2006 Mar;13(3):393-403
pubmed: 16397582
Int J Mol Sci. 2021 Mar 30;22(7):
pubmed: 33808264
F1000Res. 2018 Apr 13;7:454
pubmed: 29744037
Mol Cell. 2022 Apr 21;82(8):1477-1491
pubmed: 35452616
Eur J Immunol. 2003 Apr;33(4):899-906
pubmed: 12672055
Nat Immunol. 2010 May;11(5):411-8
pubmed: 20351694
Immunol Rev. 2015 Nov;268(1):311-27
pubmed: 26497530
PLoS One. 2012;7(8):e43547
pubmed: 22916277
PLoS One. 2016 Jun 23;11(6):e0158104
pubmed: 27337047
PLoS One. 2016 Jun 16;11(6):e0156402
pubmed: 27309732
Methods Mol Biol. 2014;1178:231-49
pubmed: 24986621
Clin Exp Allergy. 2015 Apr;45(4):788-96
pubmed: 25665021
Biol Cell. 2008 Jun;100(6):365-75
pubmed: 18181766
Mol Cell Biol. 2003 Nov;23(21):7448-59
pubmed: 14559994
Nat Commun. 2019 Nov 7;10(1):5058
pubmed: 31699981
Blood. 2004 Oct 15;104(8):2410-7
pubmed: 15217825
Chem Rec. 2006;6(6):311-9
pubmed: 17304555
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Immunol. 2007 Oct 15;179(8):5255-63
pubmed: 17911611
J Cell Biol. 2004 Oct 11;167(1):35-41
pubmed: 15466483
Cell. 2001 Dec 28;107(7):881-91
pubmed: 11779464
Clin Exp Allergy. 2017 Dec;47(12):1574-1585
pubmed: 28833704
J Immunol. 1997 Dec 15;159(12):5881-8
pubmed: 9550384
Nat Cell Biol. 2017 Jun;19(6):698-710
pubmed: 28459443
Cells. 2020 Mar 12;9(3):
pubmed: 32178254
J Immunol. 2012 Oct 1;189(7):3328-38
pubmed: 22925926
J Exp Med. 2007 Nov 26;204(12):2963-76
pubmed: 17998391
Biochem Biophys Res Commun. 2008 Jan 4;365(1):137-42
pubmed: 17980154
J Leukoc Biol. 2021 May;109(5):931-942
pubmed: 33047839
Hum Mol Genet. 2010 Jan 1;19(1):111-21
pubmed: 19819884
Nature. 2007 Jul 26;448(7152):470-3
pubmed: 17611496
Nat Immunol. 2013 Mar;14(3):298-305
pubmed: 23354484
PLoS One. 2013 Dec 12;8(12):e80743
pubmed: 24349012
Nat Immunol. 2014 Mar;15(3):248-57
pubmed: 24441789
Eur J Immunol. 2014 Mar;44(3):867-76
pubmed: 24242955
J Exp Med. 2012 Feb 13;209(2):307-18
pubmed: 22291093
Toxicol Appl Pharmacol. 2017 Oct 1;332:25-31
pubmed: 28736076
Br J Pharmacol. 1970 Jan;38(1):253-62
pubmed: 4189829
J Cell Biol. 2009 Nov 16;187(4):525-36
pubmed: 19948500
J Exp Med. 1992 Jan 1;175(1):237-44
pubmed: 1370529
Cell Calcium. 2021 Nov;99:102473
pubmed: 34560367
Nature. 2001 Jul 19;412(6844):300-7
pubmed: 11460154
Cell. 2017 Feb 9;168(4):692-706
pubmed: 28187289
Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29
pubmed: 17565364
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Biol Chem. 1996 May 31;271(22):12762-6
pubmed: 8662803
Nat Immunol. 2019 Jul;20(7):865-878
pubmed: 31086333
Oncotarget. 2017 Dec 17;9(3):2984-3000
pubmed: 29423023

Auteurs

Shatha Boukeileh (S)

The School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 9112002, Israel.

Odai Darawshi (O)

The School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 9112002, Israel.

Miriam Shmuel (M)

The School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 9112002, Israel.

Mohamed Mahameed (M)

The School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 9112002, Israel.

Thomas Wilhelm (T)

Institute of Biochemistry and Molecular Immunology, Medical School, RWTH Aachen University, D-52074 Aachen, Germany.

Priya Dipta (P)

The School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 9112002, Israel.

Francesca Forno (F)

The School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 9112002, Israel.

Bellam Praveen (B)

The School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 9112002, Israel.
Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA.

Michael Huber (M)

Institute of Biochemistry and Molecular Immunology, Medical School, RWTH Aachen University, D-52074 Aachen, Germany.

Francesca Levi-Schaffer (F)

The School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 9112002, Israel.

Boaz Tirosh (B)

The School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 9112002, Israel.
Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH